The optimal therapeutic strategy for metastatic colorectal cancer patients is still a matter of debate. There are no prognostic variables indicating how many lines individual patients ought to receive, and whether later lines could be effective even when earlier ones were not.

Treatment of Patients With Metastatic Colorectal Cancer in a Real-World Scenario: Probability of Receiving Second and Further Lines of Therapy and Description of Clinical Benefit

TAMPELLINI, MARCO;DI MAIO, Massimo;BARATELLI, Chiara;SONETTO, Cristina;LA SALVIA, ANNA;SCAGLIOTTI, Giorgio Vittorio
Last
2017-01-01

Abstract

The optimal therapeutic strategy for metastatic colorectal cancer patients is still a matter of debate. There are no prognostic variables indicating how many lines individual patients ought to receive, and whether later lines could be effective even when earlier ones were not.
2017
16
4
372
376
Activity of later lines of therapy; Advanced disease; Fourth-line therapy; Joint probabilities; Third-line therapy
Tampellini, Marco; Di Maio, Massimo; Baratelli, Chiara; Anania, Lorenzo; Brizzi, Maria Pia; Sonetto, Cristina; La Salvia, Anna; Scagliotti, Giorgio Vi...espandi
File in questo prodotto:
File Dimensione Formato  
Lines of therapy 031016.doc

Accesso riservato

Descrizione: Articolo principale post-print
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 121.5 kB
Formato Microsoft Word
121.5 kB Microsoft Word   Visualizza/Apri   Richiedi una copia
Lines of therapy 031016.pdf

Accesso aperto

Descrizione: Articolo principale post-print
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 110.1 kB
Formato Adobe PDF
110.1 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1633284
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 23
social impact